Terlipressin avoids hemodialysis in the treatment of refractory hyperkalemia associated with renal dysfunction in cirrhosis

Am J Med. 2005 Sep;118(9):1051-2. doi: 10.1016/j.amjmed.2005.04.007.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Hepatorenal Syndrome / complications*
  • Humans
  • Hyperkalemia / drug therapy*
  • Hyperkalemia / etiology*
  • Liver Cirrhosis / complications*
  • Lypressin / analogs & derivatives*
  • Lypressin / therapeutic use
  • Male
  • Middle Aged
  • Renal Agents / therapeutic use*
  • Terlipressin

Substances

  • Renal Agents
  • Lypressin
  • Terlipressin